awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33378865-D98B3D5D-8632-4387-BA60-39147A6F49C3
Q33378865-D98B3D5D-8632-4387-BA60-39147A6F49C3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33378865-D98B3D5D-8632-4387-BA60-39147A6F49C3
A phase I pharmacological and biological study of PI-88 and docetaxel in patients with advanced malignancies.
P2860
Q33378865-D98B3D5D-8632-4387-BA60-39147A6F49C3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33378865-D98B3D5D-8632-4387-BA60-39147A6F49C3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
10714c7ebde714c1ed4d805e199938424e88dbdf
P2860
Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC).